RG7287
RG7287 is an activating antibody inhibitor targeting human CDCP1. RG7287 prevents the loss of contact inhibition caused by the co-transformation of NIH3T3 cells with CDCP1 and Src in focus formation assays. RG7287 inhibits tumor cell proliferation and leads to a significant reduction in CDCP1 levels[1].
Product Specifications
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
Others
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
97.666
Smiles
[RG7287]
Precautions
H302, H315, H319, H335
References & Citations
[1]Gwendlyn Kollmorgen, et al. Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy. Mol Oncol. 2013 Dec;7 (6) :1142-51.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1002702 1.0 µg DNA
HSPG2 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
168702-AF-PE 100 µL
CD5 (CD5 antigen (p56 62), LEU1, Ly12, LyA, Lymphocyte antigen T1/Leu-1, Lymphocyte glycoprotein T1/Leu1, T-cell surface glycoprotein CD5) (PE)
Sign In for Pricing
View Details 
109001G0-AAT 25 Tests
APC/iFluor® 750 Anti-pig/ horse/ human/ non-human primates CD90 Antibody *5E10*
Sign In for Pricing
View Details GTR15171944 1 Vial
Lentiviral mouse Tnfrsf25 shRNA (UAS) - Lentiviral mouseTnfrsf25 shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details